Skip to main content

Mistrial Declared in J&J Talc Trial as Cancer Victim Dies

Mistrial Declared in J&J Talc Trial as Cancer Victim Dies

Mistrial Declared in J&J Talc Trial as Cancer Victim Dies

Introduction

Los Angeles Superior Judge Stephen Moloney announced a mistrial in Johnson & Johnson's talcum powder lawsuit alleging asbestos in the talc developed mesothelioma in the 94-year-old plaintiff. Considering the woman's death last week, the California Judge declared that the trial would not progress since certain damages were no longer allowable to the plaintiff.

The plaintiff's attorneys claimed her prolonged exposure to the talcum powder containing asbestos caused deadly cancer in her. However, the defendants argued that her pleural mesothelioma was caused by the Kent brand of cigarettes which she smoked for four to five years in the 1950s.

Thousands of cases have also been filed against J&J by plaintiffs and their families claiming exposure to asbestos-containing talc has allegedly caused ovarian cancer. Multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) was formed in 2016 in the District of New Jersey, presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. for coordinated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!